Consumer health, the business of selling health and wellness sustaining-brands in categories as diverse as pain relievers,brain-boosting yogurts.
Michael Winter
Consumer health, the business of selling health and wellness sustaining-brands in categories as diverse as pain relievers, brain-boosting yogurts, sports nutrition, baby food and bone supplement drinks, is poised to take off globally.
With consumers becoming ever more health-aware and knowledgeable, companies from both the pharma and consumer segments are competing hard to get a piece of the action.
Which players will successfully harness the segment’s potential? Whatever the outcome of the battle, talent will be a critical weapon, as interviews with C-suite executives from top food, personal care and OTC drug companies have recently shown.
The war for talent between pharma and consumer players looks set to be intense, with both sides keen - and ever more active - to lure away senior talent from their competitors to plug competence gaps and boost their own executive bench strength. This is easier said than done. Finding, attracting, convincing, and integrating this talent can be tough. It takes courage and vision for companies to move away from familiar territory and recruit a new breed of leader.
Top consumer health leaders tend to display four exceptional competency spikes.
Finding executives who meet these criteria is an issue facing consumer health businesses. In some cases they may need to take a lateral view of the talent pool, perhaps even looking to other sectors to find high-calibre leaders with the right profile.
Recruiting this kind of leadership talent, however, is merely the first step. Effective onboarding is absolutely essential. This involves companies making a serious commitment to integrating new talent. Only those companies that are truly committed to consumer health, have a clear vision and are ready to make a serious investment will attract outstanding talent that transcends the respective legacies of the pharma and consumer industries.
Michael Winter is a consultant with executive search and advisory firm Egon Zehnder.
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.